USP45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.0242029446772E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.07139963567704E-10 |
Normal-vs-Stage2 |
2.440300E-02 |
Normal-vs-Stage3 |
2.51680010165956E-10 |
Normal-vs-Stage4 |
2.51120002570104E-09 |
Stage1-vs-Stage2 |
1.407010E-01 |
Stage1-vs-Stage3 |
6.892000E-01 |
Stage1-vs-Stage4 |
6.172800E-01 |
Stage2-vs-Stage3 |
1.075560E-01 |
Stage2-vs-Stage4 |
1.018760E-01 |
Stage3-vs-Stage4 |
8.877200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.07670547425209E-11 |
Normal-vs-AfricanAmerican |
4.65982807895671E-12 |
Normal-vs-Asian |
9.260000E-02 |
Caucasian-vs-AfricanAmerican |
1.701580E-02 |
Caucasian-vs-Asian |
4.438000E-01 |
AfricanAmerican-vs-Asian |
5.060300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.20714590837679E-12 |
Normal-vs-Female |
1.23059999967978E-08 |
Male-vs-Female |
2.280000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.57589996607754E-09 |
Normal-vs-Age(41-60Yrs) |
3.30199978471057E-10 |
Normal-vs-Age(61-80Yrs) |
2.62740051937271E-10 |
Normal-vs-Age(81-100Yrs) |
1.335690E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.755500E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.722400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.280030E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.716600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.731600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.931750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.430600E-04 |
Normal-vs-Grade 2 |
1.05839999986479E-07 |
Normal-vs-Grade 3 |
3.47966100378017E-12 |
Normal-vs-Grade 4 |
1.62758695410048E-12 |
Grade 1-vs-Grade 2 |
5.917400E-01 |
Grade 1-vs-Grade 3 |
9.323400E-01 |
Grade 1-vs-Grade 4 |
2.339200E-01 |
Grade 2-vs-Grade 3 |
1.146640E-01 |
Grade 2-vs-Grade 4 |
2.214700E-04 |
Grade 3-vs-Grade 4 |
1.037910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.63780000000036E-05 |
Normal-vs-ccB subtype |
1.82986958918718E-12 |
ccA subtype-vs-ccB subtype |
3.439100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.03750000099734E-08 |
Normal-vs-N1 |
6.98350000050141E-07 |
N0-vs-N1 |
7.719700E-02 |
|
|